PET/CT Scanning Comes of Age: New IMWG Guidelines Published

Submitted by blackswan on Fri, 04/07/2017 - 03:37

New IMWG guidelines for PET/CT scanning have been published inThe Lancet Oncology. In his blog this week, IMF Chairman Dr. Brian Durie congratulates Dr. Michele Cavo and his team for their report on this extremely accurate imaging technique, used to establish a diagnosis and to monitor throughout the course of the disease. “The new IMWG guidelines provide a comprehensive review of the current role and optimal uses of FDG PET/ CT scanning,” he writes.

US FDA Lifts Partial Clinical Hold on Karyopharm’s Selinexor Clinical Trials

Submitted by blackswan on Fri, 03/31/2017 - 03:21

When there is so much that is negative in the news, it is great to be able to report today that myeloma clinical trials with selinexor (KPT-330) can again move forward.

International Myeloma Workshop: the spirit of India and the emerging myeloma community

Submitted by blackswan on Thu, 03/09/2017 - 01:38

The 16th International Myeloma Workshop was held in New Delhi, India March 1-4. This gathering of those interested in myeloma from around the world was definitely a global amalgam. The format included multiple short presentations to encompass the full range of scientific and clinical topics.

CNN profiles Black Swan Research Initiative’s innovative iStopMM project and asks “Why Iceland?”

Submitted by blackswan on Thu, 03/02/2017 - 04:56

CNN’s Chief Medical Correspondent Dr. Sanjay Gupta and his team traveled to Iceland last week to explore the country’s innovative medical projects. During their visit I was honored to have been interviewed by Dr. Gupta, along with Dr. Kári Stefánsson, Founder and CEO of deCODE Genetics, and Dr.

The Importance of Having a Plan

Submitted by blackswan on Fri, 02/17/2017 - 05:09

When a myeloma treatment or research plan comes together, it can be a great achievement. But it is unlikely to occur by chance. The goals and options need to be laid out very carefully ahead of time.

Pages

more